Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rob Pieters

Showing results (191-200 of 392) with videos related to

Pageof 40
Sort By:
Plos One|September 19, 2019
Changes in intracellular folate metabolism during high-dose methotrexate and Leucovorin rescue therapy in children with acute lymphoblastic leukemiaNatanja Oosterom, Robert de Jonge, Desiree E C Smith, et al.
Ejhaem|July 18, 2022
Decitabine mildly attenuates <i>MLL</i>-rearranged acute lymphoblastic leukemia in vivo, and represents a poor chemo-sensitizerPauline Schneider, Patricia Garrido Castro, Sandra M Pinhanços, et al.
Communications Biology|October 3, 2024
Selective inhibition of HDAC class IIA as therapeutic intervention for KMT2A-rearranged acute lymphoblastic leukemiaTamara C A I Verbeek, Kirsten S Vrenken, Susan T C J M Arentsen-Peters, et al.
Haematologica|March 2, 2016
Consensus expert recommendations for identification and management of asparaginase hypersensitivity and silent inactivationInge M van der Sluis, Lynda M Vrooman, Rob Pieters, et al.
Blood|November 16, 2002
Sensitivity to L-asparaginase is not associated with expression levels of asparagine synthetase in t(12;21)+ pediatric ALLWendy A G Stams, Monique L den Boer, H Berna Beverloo, et al.
Hemasphere|December 29, 2021
High Prevalence of Constitutional Mismatch Repair Deficiency in a Pediatric T-cell Lymphoblastic Lymphoma CohortEmma Kroeze, Dilys D Weijers, Melanie M Hagleitner, et al.
Oncotarget|April 6, 2017
Classification of pediatric acute myeloid leukemia based on miRNA expression profilesAskar Obulkasim, Jenny E Katsman-Kuipers, Lonneke Verboon, et al.
The Journal of Experimental Medicine|July 25, 2007
FBW7 mutations in leukemic cells mediate NOTCH pathway activation and resistance to gamma-secretase inhibitorsJennifer O'Neil, Jonathan Grim, Peter Strack, et al.
Haematologica|August 26, 2017
The role of constitutive activation of FMS-related tyrosine kinase-3 and <i>NRas/KRas</i> mutational status in infants with <i>KMT2A</i>-rearranged acute lymphoblastic leukemiaHenning Fedders, Ameera Alsadeq, Juliane Schmäh, et al.
Genes, Chromosomes & Cancer|November 27, 2015
Recurrent translocation t(10;17)(p15;q21) in minimally differentiated acute myeloid leukemia results in ZMYND11/MBTD1 fusionJasmijn D E de Rooij, Marry M van den Heuvel-Eibrink, Wouter J W Kollen, et al.
Pageof 40

Showing results (191-200 of 392) with videos related to

Sort By:
Pageof 40
Plos One|September 19, 2019
Changes in intracellular folate metabolism during high-dose methotrexate and Leucovorin rescue therapy in children with acute lymphoblastic leukemiaNatanja Oosterom, Robert de Jonge, Desiree E C Smith, et al.
Ejhaem|July 18, 2022
Decitabine mildly attenuates <i>MLL</i>-rearranged acute lymphoblastic leukemia in vivo, and represents a poor chemo-sensitizerPauline Schneider, Patricia Garrido Castro, Sandra M Pinhanços, et al.
Communications Biology|October 3, 2024
Selective inhibition of HDAC class IIA as therapeutic intervention for KMT2A-rearranged acute lymphoblastic leukemiaTamara C A I Verbeek, Kirsten S Vrenken, Susan T C J M Arentsen-Peters, et al.
Haematologica|March 2, 2016
Consensus expert recommendations for identification and management of asparaginase hypersensitivity and silent inactivationInge M van der Sluis, Lynda M Vrooman, Rob Pieters, et al.
Blood|November 16, 2002
Sensitivity to L-asparaginase is not associated with expression levels of asparagine synthetase in t(12;21)+ pediatric ALLWendy A G Stams, Monique L den Boer, H Berna Beverloo, et al.
Hemasphere|December 29, 2021
High Prevalence of Constitutional Mismatch Repair Deficiency in a Pediatric T-cell Lymphoblastic Lymphoma CohortEmma Kroeze, Dilys D Weijers, Melanie M Hagleitner, et al.
Oncotarget|April 6, 2017
Classification of pediatric acute myeloid leukemia based on miRNA expression profilesAskar Obulkasim, Jenny E Katsman-Kuipers, Lonneke Verboon, et al.
The Journal of Experimental Medicine|July 25, 2007
FBW7 mutations in leukemic cells mediate NOTCH pathway activation and resistance to gamma-secretase inhibitorsJennifer O'Neil, Jonathan Grim, Peter Strack, et al.
Haematologica|August 26, 2017
The role of constitutive activation of FMS-related tyrosine kinase-3 and <i>NRas/KRas</i> mutational status in infants with <i>KMT2A</i>-rearranged acute lymphoblastic leukemiaHenning Fedders, Ameera Alsadeq, Juliane Schmäh, et al.
Genes, Chromosomes & Cancer|November 27, 2015
Recurrent translocation t(10;17)(p15;q21) in minimally differentiated acute myeloid leukemia results in ZMYND11/MBTD1 fusionJasmijn D E de Rooij, Marry M van den Heuvel-Eibrink, Wouter J W Kollen, et al.
Pageof 40